Bayforest Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113K Buy
1,426
+1,179
+477% +$100K 0.1% 388
2026
Q1
$21.3K Sell
247
-1,829
-88% -$164K 0.02% 719
2025
Q4
$181K Buy
+2,076
New +$158K 0.14% 312
2025
Q3
Sell
-6,170
Closed -$364K 809
2025
Q2
$364K Buy
6,170
+1,111
+22% +$71.8K 0.16% 263
2025
Q1
$370K Buy
+5,059
New +$418K 0.16% 246

Other funds holding GMED

Bayforest Capital's GMED Position: Q2 2026 in Review

Bayforest Capital increased its Globus Medical (GMED) stake by 477% in Q2 2026, buying an estimated $100K and bringing the position to 1,426 shares worth $113K. The position accounts for 0.1% of the portfolio, ranked #388.

Bayforest Capital first reported a position in GMED in Q1 2025 and has held it in 5 quarters since. The position peaked at $370K in Q1 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Bayforest Capital held 1,426 shares of Globus Medical worth $113K as of Q2 2026.
  • Bayforest Capital bought 1,179 Globus Medical shares in Q2 2026, an estimated $100K.
  • Globus Medical made up 0.1% of Bayforest Capital's portfolio in Q2 2026, its #388 holding.
  • Bayforest Capital first reported a position in Globus Medical in Q1 2025 and has held it in 5 quarters since.
  • Bayforest Capital's Globus Medical position peaked at $370K in Q1 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.